Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jan;33(1):72–75. doi: 10.1128/jcm.33.1.72-75.1995

Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.

D R Henrard 1, S Wu 1, J Phillips 1, D Wiesner 1, J Phair 1
PMCID: PMC227882  PMID: 7699069

Abstract

Sequential specimens obtained from 87 multicenter AIDS cohort study participants were tested by three p24 antigen tests. They included a polyclonal enzyme immunoassay (EIA), a monoclonal EIA, and a monoclonal EIA after immune complex dissociation (ICD) of specimens. Subjects were grouped into two categories defined by real-time testing with the polyclonal EIA: 39 had become positive for p24 antigen (antigen converters) during follow-up, and 48 had progressed to AIDS without detectable antigenemia. Twenty-four (61%) antigen converters were positive by ICD-monoclonal EIA about 1 year earlier than by monoclonal EIA. In contrast, only 12 (25%) patients who progressed to AIDS without detectable antigenemia became positive by ICD-p24 EIA before developing AIDS. Thus, the main benefit of ICD treatment may be to detect p24 antigenemia approximately 1 year before the regular assay rather than to identify additional antigenemic people. Quantitative plasma RNA levels were also determined in longitudinal samples from 20 antigen converters and 7 men who developed AIDS without antigenemia. Although mean human immunodeficiency virus type 1 RNA levels were higher in antigen-positive than in antigen-negative samples (P = 0.002), more than half (11 of 20) of the antigen converters had no measurable change in human immunodeficiency virus type 1 RNA associated with change to antigen positivity.

Full Text

The Full Text of this article is available as a PDF (190.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bollinger R. C., Jr, Kline R. L., Francis H. L., Moss M. W., Bartlett J. G., Quinn T. C. Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. J Infect Dis. 1992 May;165(5):913–916. doi: 10.1093/infdis/165.5.913. [DOI] [PubMed] [Google Scholar]
  2. Bourinbaiar A. S. HIV and gag. Nature. 1991 Jan 10;349(6305):111–111. doi: 10.1038/349111b0. [DOI] [PubMed] [Google Scholar]
  3. Coombs R. W., Collier A. C., Allain J. P., Nikora B., Leuther M., Gjerset G. F., Corey L. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989 Dec 14;321(24):1626–1631. doi: 10.1056/NEJM198912143212402. [DOI] [PubMed] [Google Scholar]
  4. Coombs R. W., Henrard D. R., Mehaffey W. F., Gibson J., Eggert E., Quinn T. C., Phillips J. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol. 1993 Aug;31(8):1980–1986. doi: 10.1128/jcm.31.8.1980-1986.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garry R. F., Fermin C. D. Viral burden in AIDS. Nature. 1993 Sep 23;365(6444):301–302. doi: 10.1038/365301b0. [DOI] [PubMed] [Google Scholar]
  6. Ho D. D., Moudgil T., Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. doi: 10.1056/NEJM198912143212401. [DOI] [PubMed] [Google Scholar]
  7. Kageyama S., Yamada O., Mohammad S. S., Hama S., Hattori N., Asanaka M., Nakayama E., Matsumoto T., Higuchi F., Kawatani T. An improved method for the detection of HIV antigen in the blood of carriers. J Virol Methods. 1988 Dec;22(2-3):125–131. doi: 10.1016/0166-0934(88)90095-x. [DOI] [PubMed] [Google Scholar]
  8. Kaslow R. A., Ostrow D. G., Detels R., Phair J. P., Polk B. F., Rinaldo C. R., Jr The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987 Aug;126(2):310–318. doi: 10.1093/aje/126.2.310. [DOI] [PubMed] [Google Scholar]
  9. Kestens L., Hoofd G., Gigase P. L., Deleys R., van der Groen G. HIV antigen detection in circulating immune complexes. J Virol Methods. 1991 Jan;31(1):67–76. doi: 10.1016/0166-0934(91)90145-p. [DOI] [PubMed] [Google Scholar]
  10. Layne S. P., Merges M. J., Dembo M., Spouge J. L., Conley S. R., Moore J. P., Raina J. L., Renz H., Gelderblom H. R., Nara P. L. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology. 1992 Aug;189(2):695–714. doi: 10.1016/0042-6822(92)90593-e. [DOI] [PubMed] [Google Scholar]
  11. Lin H. J., Myers L. E., Yen-Lieberman B., Hollinger F. B., Henrard D., Hooper C. J., Kokka R., Kwok S., Rasheed S., Vahey M. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis. 1994 Sep;170(3):553–562. doi: 10.1093/infdis/170.3.553. [DOI] [PubMed] [Google Scholar]
  12. MacDonell K. B., Chmiel J. S., Poggensee L., Wu S., Phair J. P. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med. 1990 Dec;89(6):706–712. doi: 10.1016/0002-9343(90)90210-5. [DOI] [PubMed] [Google Scholar]
  13. Mann D. L., Carrington M., O'Donnell M., Miller T., Goedert J. HLA phenotype is a factor in determining rate of disease progression and outcome in HIV-1-infected individuals. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1345–1346. doi: 10.1089/aid.1992.8.1345. [DOI] [PubMed] [Google Scholar]
  14. Moss A. R., Bacchetti P., Osmond D., Krampf W., Chaisson R. E., Stites D., Wilber J., Allain J. P., Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):745–750. doi: 10.1136/bmj.296.6624.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Palomba E., Gay V., de Martino M., Fundaró C., Perugini L., Tovo P. A. Early diagnosis of human immunodeficiency virus infection in infants by detection of free and complexed p24 antigen. J Infect Dis. 1992 Feb;165(2):394–395. doi: 10.1093/infdis/165.2.394. [DOI] [PubMed] [Google Scholar]
  16. Paul D. A., Falk L. A., Kessler H. A., Chase R. M., Blaauw B., Chudwin D. S., Landay A. L. Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol. 1987 Aug;22(4):357–363. doi: 10.1002/jmv.1890220408. [DOI] [PubMed] [Google Scholar]
  17. Rinaldo C., Kingsley L., Neumann J., Reed D., Gupta P., Lyter D. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection. J Clin Microbiol. 1989 May;27(5):880–884. doi: 10.1128/jcm.27.5.880-884.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Saag M. S., Emini E. A., Laskin O. L., Douglas J., Lapidus W. I., Schleif W. A., Whitley R. J., Hildebrand C., Byrnes V. W., Kappes J. C. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 7;329(15):1065–1072. doi: 10.1056/NEJM199310073291502. [DOI] [PubMed] [Google Scholar]
  19. de Wolf F., Goudsmit J., Paul D. A., Lange J. M., Hooijkaas C., Schellekens P., Coutinho R. A., van der Noordaa J. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) 1987 Sep 5;295(6598):569–572. doi: 10.1136/bmj.295.6598.569. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES